Universal test and treat: How will this impact HIV stigma? - James Hargreaves

HIV-related stigma creates barriers to HIV prevention and treatment in sub-Saharan Africa, and health facilities are an important setting for HIV-related stigmatising behaviour and attitudes. Universal testing and treating of HIV (UTT), a key component of the PopART trial, may change the nature of HIV-related stigma. The webinar presents the prospective study nested within the HPTN071 (PopART) cluster randomised trial. This study aims to

  • document the domains of HIV-related stigma in interactions between social groups, and how this changes over time
  • analyse data to help increase understanding of how HIV-related stigma affects and is affected by UTT

In addition to watching the video of this Learning Lab, you can download a PDF of the presentation slides.

James Hargreaves is a Senior Lecturer at the London School of Hygiene and Tropical Medicine and Director of the School's Centre for Evaluation. James specializes in quantitative and mixed-methods evaluations using a wide array of methods including cluster randomised trials, systematic reviews and cohort, case-control and cross-section studies. His main research focus is on the social epidemiology of HIV. 

Filter by